Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 721 AL 733

Hippocampal Atrophy on Magnetic Resonance Imaging as a Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Symptomatic Alzheimer's Disease: Synthesis of Evidence from Observational and Interventional Trials

Abushakra S, Doraiswamy PM, Hey JA, Tosun D, Barkhof F, Barakos J, Petrella J, Kesslak JP, Power A, Sabbagh M, Porsteinsson A, Cohen S, Gauthier S, Ritchie C, Watson D, McSweeney E, Boada M, Liang E, Bracoud L, McLaine R, Flint S, Schaefer JF, Yu J, Bray M, Hendrix S, Dickson S, Durrant A, Albayrak A, Tolar M.

CNS Drugs. 2026 Feb;40(2):199-214. doi: 10.1007/s40263-025-01251-y. Epub 2025 Dec 1.

Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer's disease: a Bayesian meta-analysis

Ren S, Singh J, Gsteiger S, Cogley C, Reed B, Abrams KR, Dawoud D, Owen RK, Tappenden P, Quinn TJ, Bujkiewicz S.

J Comp Eff Res. 2026 Jan;15(1):e250095. doi: 10.57264/cer-2025-0095. Epub 2025 Dec 2.

Alzheimer's disease diagnosis and treatment: From pathophysiological insights to therapeutic advances in the era of precision neurology (2025 review)

Kim M, Kwon H, Sohn S, Lee WJ, Cho K, Kim GW.

J Alzheimers Dis. 2026 Jan;109(1):17-33. doi: 10.1177/13872877251391820. Epub 2025 Oct 29.

Next-generation biosensor technologies for Alzheimer's disease: Innovations in diagnosis, monitoring, and treatment

Yin C, Tang X, Zeng J, Wang Z, Mi J, Liang Y, Qin D, Feng Q, Wu A.

Ageing Res Rev. 2026 Jan;114:102954. doi: 10.1016/j.arr.2025.102954. Epub 2025 Nov 19.

Evaluating Plasma p-tau217 as an Endpoint for Alzheimer Disease Clinical Trials

Ferreira PCL, Bellaver B, Povala G, Bauer-Negrini G, Aguzzoli CS, Ferrari-Souza JP, Leffa DT, Soares C, Lussier FZ, Medeiros MS, Felix C, Ruppert E, Rohden F, Borelli WV, Karim HT, Langhough R, Christian BT, Wilson R, Hong CH, Roh HW, Patira R, Tudorascu DL, Zimmer ER, Betthauser TJ, Karikari TK, Snitz BE, Johnson SC, Son SJ, Pascoal TA.

Neurology. 2026 Jan 13;106(1):e214441. doi: 10.1212/WNL.0000000000214441. Epub 2025 Dec 9.

Real-world experience with baseline characteristics and safety of lecanemab for Alzheimer's disease in Eastern China

Leng L, Liao Z, Lu P, Sun Y, Weng Q, Fan W, Zhu H, Wu W, Liu P, Liu X, Zhang K, Wang W, Luo B, Wang Z, Peng G.

J Alzheimers Dis. 2026 Feb;109(3):1346-1356. doi: 10.1177/13872877251406619. Epub 2025 Dec 15.

The roles of biomarkers in Alzheimer's disease clinical trials

Cummings J, Sharma S, DeAndrea G, Osse AL, Ortiz A.

Neurotherapeutics. 2026 Jan;23(1):e00811. doi: 10.1016/j.neurot.2025.e00811. Epub 2025 Dec 24.

Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives

Jeong YJ, Lee HJ, Kim JS, Kim SJ, Jo U, Park JY, Jun SJ, Lee WS, Song M, Kim D, Cho G, Song JH, Hoe HS.

Med Res Rev. 2026 Jan;46(1):316-327. doi: 10.1002/med.70005. Epub 2025 Jul 31.

EEG-based stratification in Alzheimer's disease: Cognitive progression, pathological marker associations, and therapeutic interventions

Pei Z, Zhu L, Ren H, Liu Y, Shi X, Lin Y, Wang J, Li P, Wang P, Ji Y, Zhou Y, Tang X, Jiang X, Tong X, Guo Y.

Clin Neurophysiol. 2026 Jan;182:2111440. doi: 10.1016/j.clinph.2025.2111440. Epub 2025 Nov 15.

Advances in neurological therapies: A review of clinical trials in Alzheimer's, Parkinson's, and multiple sclerosis

de Souza PC, Bezerra TPW, de Melo Rêgo MJB, da Rosa MM.

Am J Med. 2026 Mar;139(3):264-275. doi: 10.1016/j.amjmed.2025.11.025. Epub 2025 Nov 27.

Unraveling the potential of gasotransmitters as neurogenic and neuroprotective molecules: focus on Alzheimer's and Parkinson's diseases

Simão S, Santos DF, Teixeira M, Agostinho RR, Rodrigues J, Vitorino M, Araújo IM.

Redox Rep. 2026 Dec;31(1):2592413. doi: 10.1080/13510002.2025.2592413. Epub 2025 Dec 15.

Speech and language outcome measures in clinical trials of Alzheimer's and Parkinson's diseases

Berthier ML, Sosa-Welford A, Orozco-Arroyave JR, López-Barroso D, Torres-Prioris MJ, Dávila G, García AM.

Expert Rev Neurother. 2026 Jan;26(1):15-34. doi: 10.1080/14737175.2025.2600616. Epub 2025 Dec 16.

Biosimilars: Antibody and nanobody-based therapeutic approaches towards protein misfolding diseases

Chinnathambi S, Rangappa N.

Adv Protein Chem Struct Biol. 2026;151:157-195. doi: 10.1016/bs.apcsb.2025.10.014. Epub 2025 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias